| 000 | 01761 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516232728.0 | ||
| 264 | 0 | _c20160329 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1555-4317 | ||
| 024 | 7 |
_a10.1002/cmmi.1619 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeven, Edwin J W | |
| 245 | 0 | 0 |
_aTherapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET. _h[electronic resource] |
| 260 |
_bContrast media & molecular imaging _c |
||
| 300 |
_a203-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacology |
| 650 | 0 | 4 |
_aThymidine _xpharmacology |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aEvers, Stefan | |
| 700 | 1 | _aNayak, Tapan K | |
| 700 | 1 | _aBergström, Mats | |
| 700 | 1 | _aSu, Fei | |
| 700 | 1 | _aGerrits, Danny | |
| 700 | 1 | _aFranssen, Gerben M | |
| 700 | 1 | _aBoerman, Otto C | |
| 773 | 0 |
_tContrast media & molecular imaging _gvol. 10 _gno. 3 _gp. 203-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cmmi.1619 _zAvailable from publisher's website |
| 999 |
_c24174571 _d24174571 |
||